BioHarvest says its platform can produce target sweetener in Tate & Lyle program
Published: 09:37 08 Oct 2026 EDT
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Thursday its Botanical Synthesis platform can produce the next-generation sweetener targeted in its joint development program with Tate & Lyle.
Tate & Lyle, a supplier of ingredient solutions for food and beverages, is looking to broaden its range of sweeteners as manufacturers seek ways to cut sugar and calories without losing taste and functionality, the companies said.
The companies said development work is continuing in line with expectations.
The result follows an expanded collaboration they announced in May 2026.
BioHarvest said its platform is designed to produce plant-derived ingredients without relying on traditional agricultural methods. It said the approach could improve consistency and supply reliability and reduce the time, labor and natural resources needed to make certain ingredients.
"Different food and beverage categories demand different balances of taste, nutrition, cost and labelling, which is why building a broader toolbox of solutions matters," said Susanna Palatucci, vice president of commercial innovation and strategy at Tate & Lyle.
"We're encouraged by the progress of the program and what it could add to our science-led approach to sweetener innovation," she said.
BioHarvest CEO Dr Zaki Rakib said the collaboration goes beyond a single development program.
"Working with Tate & Lyle brings together our platform with deep expertise in sweetening, formulation and customer needs," Rakib said.
"That combination is helping us build a clearer picture of where Botanical Synthesis can make a meaningful contribution to the future of sweetener development."